GLENMARK.NS

Glenmark Pharmaceuticals Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$168.67B

PE Ratio

14.812464188753903

EV to Ebitda

—

Earnings Yield

558516145.87%

Revenue (TTM)

$1.49B

Net Income (TTM)

$100.4M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

7.70%

Profit Margin

6.73%

Return on Equity

—

Debt to Equity Ratio

0.4130395542169883

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$168.67B

Revenue TTM$1.49B

Shares Outstanding282.2M

Float138380198

Insider Ownership53.23%

Institutional Ownership20.33%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)7.70%

Rev Growth Est 1Y Forward0.0760

EPS Growth (Quarterly YoY)1.10%

EPS Growth Est Quarterly7.93

LT EPS Growth Estimates11.20%

Operations15 fields›

Revenue TTM$1.49B

Gross Margin TTM62.83%

Gross Margin (Quarterly)64.78%

Operating Margin TTM13.47%

Operating Margin (Quarterly)14.06%

Profit Margin TTM6.73%

Profit Margin (Quarterly)7.86%

Net Income TTM$100.4M

EPS TTM29.42

EBIT Margin TTM14.60%

EBITDA TTM$217.8M

CFO % of Revenue (Quarterly)6.09%

Capex % of Revenue TTM9.07%

Capital Expenditures$135.4M

FCF % of Revenue (Quarterly)2.58%

Efficiency1 fields›

ROA6.00%

Valuation7 fields›

P/E (TTM)14.812464188753903

P/E Forward14.9031

EV/Revenues (TTM)1.2553

Price To Book1.2849682957891957

Earnings Yield558516145.87%

Dividend Yield0.00%

Payout Ratio10.78%

Liquidity7 fields›

Cash Per Share54.0367141925115

Current Ratio1.7661733374475497

Goodwill & Intangibles$24185.69T

Total Assets$180308.53T

Shareholders Equity$95730.88T

Debt to Equity0.4130395542169883

Interest Expense$2.97B

Yields3 fields›

Dividend Yield0.00%

Payout Ratio10.78%

Earnings Yield558516145.87%